Use of structural information in drug design: Current Opinion in Structural Biology 1992, 2:202–210
- 30 April 1992
- journal article
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 2 (2) , 202-210
- https://doi.org/10.1016/0959-440x(92)90147-y
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Chapter 7. Angiotensin / Renin ModulatorsPublished by Elsevier ,1991
- Comparative Modeling of Proteins in the Design of Novel Renin InhibitorsCritical Reviews in Biochemistry and Molecular Biology, 1991
- The Structure and Function of the Aspartic ProteinasesAnnual Review of Biophysics, 1990
- Renin inhibitorsMedicinal Research Reviews, 1990
- Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 Å ResolutionScience, 1989
- Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analog inhibitors containing a novel analog of statineJournal of Medicinal Chemistry, 1985
- Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by x-ray crystallography: a novel class of transition-state analogs for zinc peptidasesBiochemistry, 1984
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- The structure of carboxypeptidase A. VIII. Atomic interpretation at 0.2 nm resolution, a new study of the complex of glycyl-L-tyrosine with CPA, and mechanistic deductionsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1970